Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06503380
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-06-18
Brief Title:
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This multicenter real-world observational study will retrospectively and prospectively collect real-world data related to the investigational drugs We plan to observe 1000 patients and collect data on treatment cycles N and N1 of the targeted therapies Retrospective data collection is based on existing patient diagnosis and treatment records collecting information on patients who have completed two treatment cycles before January 1 2024 Prospective data collection is based on routine clinical treatment during the study period collected until the end of the next cycle of treatment or early termination of the study To observe the disease characteristics and management mode of hematological toxicity related to targeted therapies of breast cancer and explore the possible related factors of hematological toxicity such as age disease subtype cancer stage targeted therapy regimens etc This study will respect the medication choices of researchers in the study without specifying which medication to choose for treatment dosage mode of administration including single drug combination therapy or sequential therapy and duration of administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None